MDM Policy & Practice (Oct 2016)

Data-Driven Markov Decision Process Approximations for Personalized Hypertension Treatment Planning

  • Greggory J. Schell PhD,
  • Wesley J. Marrero BS,
  • Mariel S. Lavieri PhD,
  • Jeremy B. Sussman MD, MS,
  • Rodney A. Hayward MD

DOI
https://doi.org/10.1177/2381468316674214
Journal volume & issue
Vol. 1

Abstract

Read online

Background: Markov decision process (MDP) models are powerful tools. They enable the derivation of optimal treatment policies but may incur long computational times and generate decision rules that are challenging to interpret by physicians. Methods: In an effort to improve usability and interpretability, we examined whether Poisson regression can approximate optimal hypertension treatment policies derived by an MDP for maximizing a patient’s expected discounted quality-adjusted life years. Results: We found that our Poisson approximation to the optimal treatment policy matched the optimal policy in 99% of cases. This high accuracy translates to nearly identical health outcomes for patients. Furthermore, the Poisson approximation results in 104 additional quality-adjusted life years per 1000 patients compared to the Seventh Joint National Committee’s treatment guidelines for hypertension. The comparative health performance of the Poisson approximation was robust to the cardiovascular disease risk calculator used and calculator calibration error. Limitations: Our results are based on Markov chain modeling. Conclusions: Poisson model approximation for blood pressure treatment planning has high fidelity to optimal MDP treatment policies, which can improve usability and enhance transparency of more personalized treatment policies.